February 04, 2026 06:38 am (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Supreme Court raps Meta, WhatsApp: ‘Theft of private information, won’t allow its use’ | ‘Completely surrendered’: Congress slams Modi after Trump’s trade deal move | PM Modi thanks 'dear friend' Trump for tariff reduction, hails strong US–India partnership | Trump announces US–India trade deal, lowers reciprocal tariffs to 18% | After Budget mayhem, bulls return: Sensex, Nifty stage sharp recovery | Dalai Lama wins first Grammy at 90 | Firing outside Rohit Shetty’s Mumbai home: 4 arrested, Bishnoi Gang link emerges | Female suicide attackers emerge at centre of deadly BLA assaults that rocked Pakistan’s Balochistan | Delhi blast: Probe reveals doctors' module planned attacks on global coffee chain | Begging bowl: Pakistan PM says he feels “ashamed” seeking loans abroad
COVID-19
Normal business activities resume in Srinagar post lockdown | Image Credit: UNI

India reports over 48,000 COVID-19 cases, 1,005 deaths in 24 hours

| @indiablooms | Jul 01, 2021, at 04:29 pm

New Delhi/IBNS: In a slight increase in daily cases, India on Thursday reported 48,786 new COVID-19 infections besides registering 1,005 deaths apparently due to the virus in the last 24 hours.

In 24 hours between Wednesday and Thursday mornings, 61,588 COVID-19 patients have recovered, taking the discharge figure to 2,94,88,918.

As per the Health Ministry's data, the country's active cases have decreased to 5,23,257.

The daily recoveries have outnumbered the new infections for the 49th straight day.

The South Asian country, which has centralised its vaccination policy from Jun 21, has so far inoculated 33.57 crore people aged 18 or more.

Giving more strength to India's vaccination drive, native drug making company Zydus Cadila has applied to the country's drug regulator (DCGI) for an emergency use approval of its anti-COVID-19 vaccine, named ZyCov-D.

Four vaccines, Moderna, AstraZeneca's Indian version Covishield, indigenous Covaxin and Russia's Sputnik, have so far been approved by the country for their uses.

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.